A detailed history of Susquehanna International Group, LLP transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 33,800 shares of AURA stock, worth $277,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,800
Holding current value
$277,160
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$7.09 - $9.24 $53,657 - $69,928
7,568 Added 69.91%
18,394 $144,000
Q4 2023

Feb 14, 2024

BUY
$7.02 - $11.98 $75,998 - $129,695
10,826 New
10,826 $95,000
Q1 2023

May 16, 2023

BUY
$8.88 - $12.11 $91,845 - $125,253
10,343 New
10,343 $95,000

Others Institutions Holding AURA

About Aura Biosciences, Inc.


  • Ticker AURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,273,600
  • Market Cap $240M
  • Description
  • Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...
More about AURA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.